Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
fMDA vs RACD for Malaria in Swaziland
NCT02315690Phase 3Completed
- Sponsor
- University of California, San Francisco
- Start
- Sep 2015
- Primary completion
- Jul 2017
- Modality
- Bivalent/Multivalent Binders, Nucleic Acid-Directed Small Molecules, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of dihydroartemisinin + piperaquine in malaria, sponsored by University of California, San Francisco. Started Sep 2015; status: completed.
02
Drugs
dihydroartemisinin + piperaquine
03
Conditions
malaria
Beyond the preview
Go deeper on NCT02315690.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02315690.